Teva's latest quarter was even worse than already-low expectations - MarketWatch
Drug Stock Due for Another Climb on the Charts
Teva - Updates, News, Events, Signals & Triggers
Teva shares surge on corporate shake-up - MarketWatch
Teva Stock Falls Because 2019 Will Be a 'Trough Year' | Barron's
Teva shares hit 19-year low after opioid settlement, analyst downgrades | Fierce Pharma
Teva and Other Opioid Defendant Stocks Jump on Strong Earnings | Barron's
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Is Teva A Falling Drug Company Or A Great Value Proposition (NYSE:TEVA) | Seeking Alpha
Teva's CEO Kåre Schultz to retire at year end, succeeded by Richard Francis
Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Teva's Battered Stock Looks Extremely Cheap | Barron's
TEVA -- Is Its Stock Price A Worthy Investment? Learn More.
Teva Stock Soars After Reaching $4.25 Billion Opioid Settlement | Barron's
Teva Pharmaceuticals - Wikipedia
Investors wary of Teva-Mylan merger - MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Warren Buffett Stocks Fall: Teva Pharmaceutical Up 1.8%; StoneCo Off 3.7% - TheStreet
Teva Pharmaceutical Is Bottoming: Here's My Strategy - RealMoney
Teva Pharmaceuticals - Wikiwand
Teva Pharmaceutical Industries - Recent News & Activity
Teva Appoints New Chief Executive After Months of Speculation - WSJ
